18th Annual Clinical Trial Supply West Coast 2026

Master Emerging Trends, Tackle Global Bottlenecks, and Leverage New Technologies to Build a More Resilient, Optimized Clinical Supply Chain

22 - 23

September

2026
  • Hyatt Regency San Francisco Airport, Burlingame, USA
  • Complimentary
  • Why attend?
  • Agenda
  • Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • 2026 Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Featured Speakers

Back

Nick Vyas​

Professor, Clinical Data Sciences and Supply Chain Operations, Marshall School of Business

Next speaker
Back

Monica Eris​

Senior Director, Head of Supply Chain, Logistics & CMO Management, Imugene Limited

Next speaker
Back

Jason Keveryn​

Associate Director, Clinical Supply Chain, Cytokinetics

Next speaker
Back

Pooja Gandhi​

Director, Clinical Quality Assurance, Grail

Next speaker
Back

Shubhra Kochar​

Global Strategy Lead Comparator Management, Clinical Supply Planning, Genentech

Next speaker

    2026 Sponsors Include:

    Back

    Company Information

    Valeris is a trusted life sciences commercialization partner offering end-to-end solutions across the healthcare value chain. With deep industry expertise, advanced technology, and a patient-first approach, Valeris helps life sciences companies enhance access, adherence, and outcomes. Serving over 500 clients, the company delivers data insights, patient support, and provider engagement tools that drive product success. Headquartered in North Carolina and Indiana, Valeris has supported millions of patients. Learn more at www.valeris.com.

    Next Sponsor
    Back

    Company Information

    IQVIA delivers AI‑powered clinical technologies that simplify trial operations, improve patient and site experiences, and accelerate clinical development. Our secure, SaaS‑based platforms use healthcare‑grade AI to streamline workflows, reduce administrative burden, and enable smarter, faster decision‑making across the clinical trial lifecycle.

    Company Website

    To learn more, please visit our website - https://www.iqvia.com/solutions/technologies

    Next Sponsor
    Back

    Company Information

    The PPD clinical research business of Thermo Fisher Scientific enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services.

    Company Website

    To learn more, please visit our website - https://thermofisher.com/ppd

    Next Sponsor
    Back

    Company Information

    Inceptua is a global pharmaceutical services company with market-leading capabilities across multiple business areas.

    – Inceptua Clinical Trial Supply and Clinical Services provides clinical trial supply, services and logistics, including comparator sourcing of medicines, packaging, labelling, storage, and distribution services

    – Inceptua Early Access offers strategic advice, design, facilitation, and implementation of global early access programs, and distributes unlicensed and other medicines worldwide.

    Inceptua has over 25 years of experience serving life science companies of various sizes, and has global operations with offices across Europe, North America, and Asia, including China.

    Additional information is available at: www.inceptua.com

    Next Sponsor
    Back

    Company Information

    QuickSTAT provides 24/7/365 trusted global life science logistics and transportation solutions for companies worldwide combining industry expertise and innovative technology. Our team of logistics experts specializes in time- and temperature-sensitive shipping of clinical research samples, CGT, vaccines, investigational drugs, CTS, etc., helping bring new drugs and medical protocols to market.

    Company Website

    To learn more, please visit our website - www.quickstat.com

    Next Sponsor
    Back

    Company Information

    Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle.

    We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution.

    We are recognised as an industry leader in client service, providing understanding, experience and knowledge to our clients as we work together to advance human health.

    Almac is trusted by the leading global biopharma companies to provide crucial services across their drug development projects. In the last 5 years alone, we have contributed to over 50% of all FDA approved New Molecular Entities (NMEs) and are currently supporting 30% of EU approved /pre-registered Gene therapy products.

    A privately owned organisation, Almac has grown organically over the past five decades, employing over 7,700 highly skilled employees across 18 facilities in Europe, North America, and Asia. Learn more about us at https://www.almacgroup.com/

    Company Website

    To learn more, please visit our website - https://www.almacgroup.com

    Next Sponsor
    Back

    Company Information

    YPrime’s cloud-based technology streamlines clinical trial data collection and management. Electronic clinical outcome assessments (eCOA) and interactive response technology (IRT) platforms introduce greater speed, precision and data quality to clinical trials. Our consulting services help clients simplify downstream processes, while moving faster and more efficiently to their next development milestone.

    We innovate through pragmatic, forward-looking change that considers the needs of stakeholders in each clinical research role. We’re doing more than streamlining your processes. We’re streamlining your research, helping you get to your next milestone faster.

    Company Website

    To learn more, please visit our website - http://www.yprime.com/

    Next Sponsor
    Back

    Company Information

    Euromed Pharma deliver strategic services tailored to support companies in their quest to better healthcare. We support each industry player from drug development through the post-marketing phases. We offer solutions in CTS services, Clinical GMP Packaging, Labeling and Distribution, IMP management, Early Access and Named Patient Programs, Pharma Order to cash solutions, and Supply Chain & Logistics. We are present around the world with offices in Italy, Spain, Ireland, Germany, Singapore and the USA. Being one of the Petrone Group companies, Euromed Pharma is positioned at the forefront of innovation in pharmaceutical distribution.

    Company Website

    To learn more, please visit our website - www.euromed-pharma.com

    Next Sponsor
    Back

    Company Information

    Simply sourcing comparators – we offer a unique blend of small company flexibility and speed, backed with the large-scale buying power of the Orifarm Group, which is one of the largest pharmaceutical suppliers in Europe. With over €1.4B products sold in 2021 and more than 4,000 unique product lines sourced on a monthly basis, we have unparalleled access to “out of market” and manufacturer direct buying capability, both in the US and Europe.

    Company website: www.Orifarm-CTS.com

    Company Website

    To learn more, please visit our website - www.Orifarm-CTS.com

    Next Sponsor
    Back

    Company Information

    4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. For more information, please visit www.4gclinical.com

    Company Website:http://www.4gclinical.com/

    Next Sponsor
    Back

    Company Website

    To learn more, please visit our website - http://www.bappharma.com/

    Next Sponsor
    Back

    Company Information

    Catalent solves today’s clinical trial supply challenges and develops innovative solutions for the future. Catalent’s commitment to quality and service excellence is evident in its comprehensive and flexible solutions for small molecules, biologics and advanced therapy medicinal products (ATMPs). With modern global facilities, and 25+ years’ experience reliably supplying thousands of studies of all sizes and complexities around the world, services include:

    • Clinical supply management
    • Integrated formulation development, clinical manufacturing & blinding
    • Specialty handling (potent, cytotoxic, controlled)
    • Direct commercial product sourcing
    • Clinical packaging/labeling
    • Extensive clinical storage, cold chain capabilities & global distribution
    • Demand-led supply
    • Direct-to-patient solutions
    • Clinical returns, reconciliation & destruction.

    Company Website

    To learn more, please visit our website - https://clinical.catalent.com/

    Next Sponsor
    Back

    Company Information

    Jupiter Research Services is a global, one-stop solution for comprehensive clinical supply chain management.

    We specialize in Comparator Sourcing, Labeling, Secondary Packaging, and Temperature-Controlled Storage & Distribution, with regulatory compliant GxP facilities, delivering end-to-end support to the pharmaceutical, biopharma, CRO, and CMO industries.

    Our quality-focused, tailor-made services are designed to ensure the most efficient delivery of effective and accessible treatments worldwide.

    Company Website

    To learn more, please visit our website - www.jrsllc.com

    Next Sponsor
    Back

    Company Information

    The CCL Clinical Business Unit is the global specialist of CCL Industries Inc. for products and services in the clinical trials sector. Leveraging over two decades of expertise and operating across various manufacturing sites, we stand poised as your premier partner for clinical trial labeling. With a combined portfolio, worldwide reach, and dedicated local assistance, CCL Clinical emerges as your ultimate destination for excellence in clinical trial labeling services.

    Company Website

    To learn more, please visit our website - www.CCLClinical.com

    Next Sponsor
    Back

    Company Information

    N-SIDE is a deeptech company that empowers organizations in the life sciences to make better decisions and optimize the use of critical resources. We’re doing so by combining deep industry expertise with applied mathematics and artificial intelligence into easy to use and cutting-edge software that transforms uncertainty and complexity into deterministic outcomes. We are an active player in clinical trial supply chain management for over 20 years and have the majority of the top 20 pharmaceutical companies as clients.

    With our software solution, the N-SIDE Suite, and expert services, we streamline the clinical supply of pharmaceutical and biotech companies by accelerating clinical plans, mitigating risks and curbing drug waste. We empower clinical leaders to make better, faster and safer decisions for patients waiting for life-changing medications.

    Company Website

    To learn more, please visit our website - https://lifesciences.n-side.com/

    Next Sponsor
    Back

    Company Information

    Since 1997, Clinigen has offered market-leading clinical trial supplies and biological sample management services to meet the most complex clinical supply challenges. Part of Clinigen Group’s global supply chain facility and depot network, we deliver tailored solutions for clients to ensure their clinical trials are a success, regardless of size or scope, from Phase I to Phase IV projects.

    Company Website

    To learn more, please visit our website - www.clinigencsm.com

    Next Sponsor

      Why attend?

      Solving the Global Clinical Supply Puzzle!

      As international trials grow more complex, your strategy must evolve. We’re exploring how to integrate cutting-edge technology and streamlined protocols to ensure your clinical supply chain is as agile as the science it supports.

      Two Days of Insight. Infinite Connections.

      Immerse yourself in a high-impact program of presentations, interactive roundtables, and expert panels. From tackling global supply chain bottlenecks to adopting emerging trends, this is your unmissable opportunity to gain the tools and the network you need to lead the industry.

      Get in touch now and secure your place!

      WHAT TO EXPECT FOR 2026?

      Master Strategy. Build Connections. Drive Success.

      Join the premier gathering for the Californian pharma and biotech community.

      Discover how to excel in supply chain execution while building the strategic connections your future demands.

       

       

       

      200+

      Attendees

      		25+

      Exhibitors

      		20+

      Speakers
      200+

      Attendees

      		25+

      Exhibitors
      20+

      Speakers

      Testimonials

      See What It's All About

      Agenda

      • 22 Sep 2025
      • 23 Sep 2025
      Expand All

      Streams

      11:30 AM

      PANEL: Clinical supply chain innovation: insights into new technology and strategy

      • Cutting edge technologies and incorporating these into your clinical supply chain
      • Sustainability and incorporating eco-friendly initiatives in clinical supply chain management
      • Collaborative platforms: improving communication and efficiency among stakeholders
      • Success stories, transformative case studies and key takeaways

      MODERATOR: Luiz Barberini, Head of External Manufacturing, Latin America, Bayer

      Speakers

      Prasun Mishra
      Founding Director, Chairman of the Board, Agility Pharmaceuticals
      Luiz Barberini
      Head of External Manufacturing, Latin America, Bayer
      Tom Gottschalk
      Vice President Business Development, RxStudy Card by Valeris

      12 PM

      Biotech speed, biopharma scale: powered by clinical trial innovation

      • Strategies for reducing clinical supply waste while ensuring patient needs are met
      • Digital tools that enhance real-time visibility into supply shipments and their status
      • Operational innovations that enable faster timelines without increasing risk
      • Practical approaches to aligning supply chain efficiency with clinical trial demand

      Speakers

      Kirk Bray
      Senior Manager, Commercial Operations, Thermo Fisher Scientific

      12:30 PM

      Innovation in comparator sourcing processes for your clinical trial

      • Designing your comparator sourcing strategy: key factors to consider for your clinical trial
      • Exploring strategies for reliable and cost-effective sourcing: what solutions are available?
      • Addressing regulatory considerations and compliance challenges for comparator sourcing both in the US and from overseas
      • Leveraging technology and data analytics to streamline comparator sourcing processes

      Speakers

      Brenda Nguyen
      Director, Clinical Supply, BridgeBio Oncology Therapeutics

      1 PM

      Lunch and networking

      2:15 PM

      Assessing clinical materials risk: ensuring supply continuity and compliance

      • Evaluating sourcing, shelf-life and regulatory constraints for high risk items
      • Mapping global supply chain dependencies and transit vulnerabilities
      • Implementing strategies to mitigate against supply chain risk
      • Collaborating cross-functionally to align risk assessment with trial timelines and priorities

      Speakers

      Horacio Enriquez
      Former Senior Director, Supply Chain, Amgen

      2:45 PM

      Support as Strategy: Turning Technical Expertise into Operational Wins

      Support teams are often seen as reactive problem-solvers—but what happens when they’re embedded early in the trial lifecycle? This session explores how technical support can play a proactive role in study success. We’ll discuss how early involvement in processes like the Study Maintenance Plan and Go-Live allows support teams to anticipate challenges, prepare sponsors and sites, and respond more effectively when issues arise. Join us for a practical conversation on how collaboration and foresight can make support a strategic asset in clinical trial delivery.

      Speakers

      Lauren Skinner
      Technical Support Lead, Endpoint Clinical

      3:15 PM

      Afternoon refreshments and networking

      11:30 AM

      Mitigating risk and planning for unforeseen circumstances: protecting your clinical supply chain

      • Preparing for the unexpected: building contingency protocols in from the start of a trial
      • Planning for unforeseen events and incorporating this into your risk management strategy
      • Incorporating risk assessment into project management plans in order to be better prepared for every eventuality
      • How to reduce risk caused by supply chain delays

      Speakers

      Umar Hayat
      Founder, CEO, Accanito Therapeutics Inc

      12 PM

      Best practice in planning and forecasting: ensuring accuracy and efficiency

      • Data-driven insights: utilizing data analytics for informed forecasting decisions
      • The importance of remaining flexible to adapt to changing trial dynamics and demands
      • Proactive risk management: identifying and mitigating potential obstacles to streamline forecasting processes
      • Effective forecasting in order to reduce waste, cost and carbon footprint

      Speakers

      Rachael Pierce
      Senior Manager Clinical Supply, Arrowhead Pharmaceuticals

      12:30 PM

      Collaboration between supply planning, process development and production to enable clinical trial supplies

      • The basics of drug substance manufacturing and what drives uncertainty in yields, especially in early phase production
      • Recommendations and tactics for how supply chain planners should coordinate early and often with counterparts in CMC and manufacturing to stay abreast of expected yields, lead times, sampling requirements
      • Understanding risks

      Speakers

      Leah Frautschy
      Vice President, Clinical Manufacturing, Denali Therapeutics

      1 PM

      Lunch and networking

      2:15 PM

      T-cell immunotherapy: trends and insights shaping clinical development

      • Overview of the T-cell immunotherapy landscape
      • Trends in regulatory approvals and designations impacting trial timing and logistics
      • Market outlook and projected growth through 2031 and the implications for supply planning
      • Clinical trial insights, including leading countries and key challenges affecting trial execution

      Speakers

      Eleni Tokali
      Drug Intelligence Analyst, GlobalData

      2:45 PM

      Understanding duty rate and entry rates in US clinical supply chain imports

      • Classifying clinical materials correctly to avoid delays or unexpected costs
      • Collaborating with brokers and logistics partners to ensure compliant, efficient importation
      • Determining duty rates and entry rates for different types of clinical trial materials and products
      • Applying for duty exemptions: are you eligible?

      Speakers

      Brandy Porter
      Assistant Center Director, Enforcement Pharmaceuticals, Health, and Chemicals Center of Excellence and Expertise, U.S. Customs & Border Protection

      3:15 PM

      Afternoon refreshments and networking

      4 PM

      PANEL: Breaking down silos: fostering collaboration between clinical operations and clinical supply teams

      • Interacting earlier for supply to give input and gain information sooner so they can assist and be prepared
      • Establishing clinical team needs: what, when and where
      • Building and maintaining strong relationships between teams

      Speakers

      Christine von Raesfeld
      Patient Advocate, The Light Collective
      Evan L. Wohl, R.Ph.
      Director, Clinical Supplies, Ionis Pharmaceuticals
      Leah Frautschy
      Vice President, Clinical Manufacturing, Denali Therapeutics
      Umar Hayat
      Founder, CEO, Accanito Therapeutics Inc
      Cara Woodruff
      Director Product Management, IT Design and Development, IQVIA IRT

      4:45 PM

      Chairperson’s closing remarks

      Speakers

      Paul Hingst
      Supply Chain Consultant, Crinetics Pharmaceuticals

      5 PM

      NETWORKING DRINKS

      8 AM

      Registration and refreshments

      8:45 AM

      Chairperson’s opening remarks

      Speakers

      9 AM

      SPEAKER HOSTED ROUNDTABLE DISCUSSIONS

      Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the clinical supply chain industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others. Each roundtable will last for 45 minutes, after which delegates will be given the opportunity to swap to a different roundtable.

      ROUNDTABLE 1: Topic TBC
      Carmin Cerullo, Agriculture Operations Manager, San Francisco and Portland Field Office, U.S. Customs and Border Protection
      Jolien Wychules, Biological Threat Operations Specialist, San Francisco and Portland Field Office, U.S. Customs and Border Protection

       

      ROUNDTABLE 2: Topic TBC
      Luiz Barberini, Head of External Manufacturing, Latin America, Bayer

       

      ROUNDTABLE 3: Data, analytics and GenAI in clinical supply chains

      Speakers

      Carmin Cerullo
      Agriculture Operations Manager, San Francisco and Portland Field Office, U.S. Customs and Border Protection
      Jolien Wychules
      Biological Threat Operations Specialist, San Francisco and Portland Field Office, U.S. Customs and Border Protection

      10:30 AM

      Morning refreshments and networking

      11:15 AM

      KEYNOTE CASE STUDY: Ensuring excellence: quality assurance and control in clinical trial supply

      • Understanding FDA regulations and guidelines for ensuring quality and integrity
      • Implementing GMP standards to maintain consistency and reliability in production and distribution of trial materials
      • Adopting a risk-based approach to quality management
      • Establishing robust supplier qualification processes to select reliable partners and ensure adherence to quality standards

      Speakers

      Naymisha (Isha) Patel
      Senior Vice President, Quality, Tenaya Therapeutics

      11:45 AM

      Outsourcing and working with suppliers: making a success of your vendor relationships

      • Selecting the right suppliers: criteria for evaluating and choosing temperature controlled logistics partners
      • Building strong partnerships: fostering effective communication and collaboration with suppliers
      • Best practices in drafting and managing contracts and supplier agreements
      • Feedback mechanisms and performance reviews to enhance supplier relationships and logistics processes

      Speakers

      Luiz Barberini
      Head of External Manufacturing, Latin America, Bayer

      12:15 PM

      PATIENT ADVOCACY KEYNOTE: From protocols to patients: redesigning supply chains for real world impact

      • Explore how integrating patient perspectives into clinical supply chain planning can reduce trial burden, improve retention, and build long term trust. This session will highlight best practices in collaborating with advocacy groups, designing flexible logistics, and aligning operational excellence with patient experience.

      Speakers

      Christine von Raesfeld
      Patient Advocate, The Light Collective

      12:45 PM

      Lunch and networking

      2 PM

      PANEL: Sourcing vendors and partners for your clinical supply chain: what are the most important considerations?

      • Balancing cost alongside other considerations when selecting vendors
      • Key factors to consider when choosing vendors and partners in clinical supply
      • Advantages and disadvantages of choosing large vs small vendors
      • Working with international partners: additional challenges and how to address these

      MODERATOR: Christine Von Raesfeld, Board Member and Lived Experience Expert, The Light Collective

      Speakers

      Christine von Raesfeld
      Patient Advocate, The Light Collective
      Umar Hayat
      Founder, CEO, Accanito Therapeutics Inc
      Evan L. Wohl, R.Ph.
      Director, Clinical Supplies, Ionis Pharmaceuticals
      Christopher Ohms
      Executive Director Supply Chain, Rigel Pharmaceuticals

      2:45 PM

      Importation requirements and best practices for importing biological materials into the United States

      • Ensuring biological materials comply with CBP and multi-agency regulations
      • Understanding import requirements in the trade environment and when traveling with biological materials
      • Preventing common discrepancies to avoid delays which can be costly and impact research

      Speakers

      Carmin Cerullo
      Agriculture Operations Manager, San Francisco and Portland Field Office, U.S. Customs and Border Protection
      Jolien Wychules
      Biological Threat Operations Specialist, San Francisco and Portland Field Office, U.S. Customs and Border Protection

      3:15 PM

      Afternoon refreshments and networking

      3:15 PM

      PANEL: Leveraging IRT and forecasting in a complex Phase 1 trial

      • Designing flexible IRT systems to accommodate multiple dose levels and protocol adaptations
      • Forecasting clinical supply needs amid uncertainty in dosing, cohorts and timelines
      • Collaborating across functions to align IRT, supply and clinical execution
      • Applying lessons learned from a real world CNS program with high complexity and unpredictability

      MODERATOR: Luiz Barberini, Head of External Manufacturing, Latin America, Bayer

      Speakers

      Charisse Eary
      Executive Director, Head of Quality, Aligos Therapeutics
      Louie Burks
      Director, Clinical Supply, Praxis Precision Medicines
      Maryam Rafiei
      Head of Quality, Aligos Therapeutics
      Cara Woodruff
      Director Product Management, IT Design and Development, IQVIA IRT
      Luiz Barberini
      Head of External Manufacturing, Latin America, Bayer

      3:45 PM

      Afternoon refreshments and networking

      4:20 PM

      EXHIBITION APPLE PRIZE DRAW

      Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

      4:30 PM

      END OF CONFERENCE

      Speakers

      Select a speaker to learn more

      Back
      Jessica Lee
      Division Director, Division of West Coast Imports, FDA

      Session Details:

      OPENING REGULATORY KEYNOTE: Navigating 2026 Mandates: The importation landscape for medical products & Clinical supplies

      2026-09-22, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Marissa Chan
      Supervisor, Division of West Coast Imports, FDA

      Session Details:

      OPENING REGULATORY KEYNOTE: Navigating 2026 Mandates: The importation landscape for medical products & Clinical supplies

      2026-09-22, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Monica Eris
      Senior Director, Head of Supply Chain, Logistics & CMO Management, Imugene Limited
      Next speaker
      Back
      Shubhra Kochar
      Global Strategy Lead Comparator Management, Clinical Supply Planning, Genentech
      Next speaker
      Back
      Rutesh Desai
      Director, Global Supply Chain Capabilities, BeOne Medicine
      Next speaker
      Back
      Jason Keveryn
      Associate Director, Clinical Supply Chain, Cytokinetics
      Next speaker
      Back
      Naymisha (Isha) Patel
      Senior Vice President, Quality, Tenaya Therapeutics

      Accomplished Quality and Regulatory professional with 25 years of progressive experience in pharmaceuticals, biologics, medical devices, and combination products from early stage to late stage and commercialization.
      Proven track record of significant contributions in quality management, pre-approval inspections, commercial launch, regulatory submissions, process improvement, supplier management, regulatory compliance, and implementation of quality management systems in a wide range of organizations that previously had no/minimal quality programs in place.
      Established clinical quality assurance function in clinical trials globally. This includes QA review of clinical trial documents, data integrity assurance, GCP compliance at investigator sites, clinical vendor (CRO) qualification, management and audit, independent GCP quality audits and supporting clinical CAPA.

      Session Details:

      KEYNOTE CASE STUDY: Ensuring excellence: quality assurance and control in clinical trial supply

      2025-09-10, 11:15 AM

      View In Agenda
      Next speaker
      Back
      Ted Chun
      VP Regulatory, Quality & Clinical, Prometheus Therapeutics
      Next speaker
      Back
      Pooja Gandhi
      Director, Clinical Quality Assurance, Grail
      Next speaker
      Back
      Heidi Hoffmann
      VP, ADC Development and Manufacturing IDEAYA Biosciences
      Next speaker
      Back
      Malinda Longphre
      Head of Clinical Operations, Attovia Therapeutics
      Next speaker
      Back
      Jamie Goldman
      Logistic Program Manager, Orca Bio
      Next speaker
      Back
      Tom Schiavon
      Clinical Systems (IRT) & Technology Manager, Insmed Incorporated

      Tom is currently serving as a Senior UAT Analyst for Bristol Myers Squibb. Most recently, he worked in clinical systems role for Ultragenyx Pharmaceutical, overseeing IRT, CTMS, eCOA, eConsent, CGM, and wearables systems and processes. Previously, he worked as an IRT senior project manager at Amgen, built and managed international technical support and data management teams, and worked as an IRT project manager, both at endpoint clinical. He has managed projects in the therapeutic areas of hematology & oncology, pain, bone, cardiovascular, and dermatology, from early-phase oncology through post-marketing studies. He graduated summa cum laude with a B.A in Philosophy and History from Florida Gulf Coast University, where he also earned an M.A. in English. He has published several articles on process improvement, change management, and making IRT concepts more accessible to sponsor study management personnel.

      Next speaker
      Back
      Paul Hingst
      Supply Chain Consultant, Crinetics Pharmaceuticals

      Paul is an experienced Clinical Supply Chain Professional with a 25-year career in the BioPharmaceutical industry.  His extensive career includes roles at major companies like Amgen and Thermo Fisher Scientific, where he honed his skills and made a significant impact.  He has served in varied roles from basic research and contract manufacturing to client services and account management.  He is a Principal Consultant and Co-Founder of Beacon BioPharm Associates, a clinical supply chain consulting firm, providing variable staffing solutions to small and mid-sized BioPharm clients.  Paul is an industry veteran and respected leader known for his expertise in clinical supply chain.

      Session Details:

      Chairperson’s closing remarks

      2025-09-09, 4:45 PM

      View In Agenda
      Next speaker
      Back
      Umar Hayat
      Founder, CEO, Accanito Therapeutics Inc

      Umar Hayat, Ph.D. is VP of CMC and Supply Chain at Union Therapeutics and has more than two decades of experience in pharmaceutical development, manufacturing and supply chain. He held senior level positions with Relypsa (acquired by Galenica for 1.52B US$), Anacor (acquired by Pfizer for 5.2B US$) and Transcept Pharmaceuticals (revers merger with Paratek). He played a pivotal role in the development and commercialization of Veltassa® (USA and EU), a treatment for hyperkalemia, Intermezzo® for MOTN insomnia, Kerydin® for onychomycosis, and Eucrisa® for atopic dermatitis. Dr. Hayat is managing partner of Revive Pharm USA. He is also a co-founder of U&D Pharma and working on Replyte Gel, a treatment for anogenital warts. Dr. Hayat received his Ph.D. in process engineering from INP-Toulouse, France and Post-Doctoral Fellowship from Ecole Polytechnique de Montreal, Canada. He received M.Sc. Chemistry degree from Punjab University, Institute of Chemistry

      Session Details:

      Mitigating risk and planning for unforeseen circumstances: protecting your clinical supply chain

      2025-09-09, 11:30 AM

      Session Details:

      PANEL: Breaking down silos: fostering collaboration between clinical operations and clinical supply teams

      2025-09-09, 4:00 PM

      Session Details:

      PANEL: Sourcing vendors and partners for your clinical supply chain: what are the most important considerations?

      2025-09-10, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Rabindra Shivnaraine
      Director, Aerys Biosciences
      Next speaker
      Back
      Charisse Eary
      Executive Director, Head of Quality, Aligos Therapeutics

      Session Details:

      PANEL: Leveraging IRT and forecasting in a complex Phase 1 trial

      2025-09-10, 3:15 PM

      View In Agenda
      Next speaker
      Back
      Dr. Prasun Mishra
      Co-Founder & CEO, Precision BioPharma
      Next speaker
      Back
      Bruno Larida
      Chief Business Officer, Omios Biologics
      Next speaker
      Back
      Jin Lee
      Founding Board Member, CURE NDD
      Next speaker
      Back
      David Larwood
      CEO, Valley Fever Solutions

      Dr. David Larwood brings a rare combination of scientific innovation and business acumen to the fight against Valley Fever, a serious and often overlooked fungal disease. While pursuing his PhD in chemistry and chemical biology at UCSF, Dr. David Larwood explored the therapeutic potential of brilacidin, an antimicrobial compound with promising activity against fungal pathogens such as coccidioides, the organism responsible for Valley Fever, which disproportionately affects immunocompromised individuals. At UCSF, he invented PEGylated lipids and with his advisor made the first ever PEGylated liposomes, which lets the “payload” content circulate much longer in the bloodstream, making new forms of delivery possible. The delivery system is integral to Doxil, a drug that treats various cancers. It also is critical to the mRNA COVID vaccines. He was also the first to synthesize Iotrolan, a widely used contrast agent in medical imaging such as X-rays and CT scans, producing more effective clinical diagnostics. His doctoral work was the foundation of a robust career at the convergence of pharmaceutical chemistry and biotech innovation.

       

      Today, Dr. Larwood is founder, president, and CEO of Valley Fever Solutions, where he leads a team working to advance Nikkomycin Z (NikZ), a targeted antifungal therapy. With $7 million in NIH support and a collaborative research team, Dr. Larwood is driving efforts to improve treatments in the regions most affected by Valley Fever, including the Southwestern U.S., Mexico, and Central and South America. Dr. Larwood's 2020 review of NikZ therapy has been cited more than 37 times and continues to inform the field.

      Next speaker
      Back
      Brandy Porter
      Assistant Center Director, Enforcement Pharmaceuticals, Health, and Chemicals Center of Excellence and Expertise, U.S. Customs & Border Protection

      Brandy Porter is the Assistant Center Director for Enforcement, of CBP’s Pharmaceutical, Health, and Chemicals Center of Excellence and Expertise (PHC CEE). PHC CEE oversees imports of pharmaceuticals, healthcare, medical equipment, and chemicals into the United States. Prior to her work at PHC CEE, Ms. Porter was the Deputy Assistant Director for the Center for Intelligence, Targeting, and Enforcement, located in the New York Field Office.  She began her career with CBP in 2009, as an analyst.

      Session Details:

      Understanding duty rate and entry rates in US clinical supply chain imports

      2025-09-09, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Carmin Cerullo
      Agriculture Operations Manager, San Francisco and Portland Field Office, U.S. Customs and Border Protection

      Session Details:

      SPEAKER HOSTED ROUNDTABLE DISCUSSIONS

      2025-09-10, 9:00 AM

      Session Details:

      Importation requirements and best practices for importing biological materials into the United States

      2025-09-10, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Jolien Wychules
      Biological Threat Operations Specialist, San Francisco and Portland Field Office, U.S. Customs and Border Protection

      Session Details:

      SPEAKER HOSTED ROUNDTABLE DISCUSSIONS

      2025-09-10, 9:00 AM

      Session Details:

      Importation requirements and best practices for importing biological materials into the United States

      2025-09-10, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Sia Zadeh
      Chair AI Initiative and Associate Professor and Data Scientist, Golden Gate University
      Next speaker
      Back
      Nick Vyas
      Professor, Clinical Data Sciences and Supply Chain Operations, Marshall School of Business

      Session Details:

      GEO SPOTLIGHT: Building a Rock-Solid clinical supply chain: Protecting trial continuity and revenue amidst geopolitical and economic turmoil!

      2026-09-22, 9:50 AM

      View In Agenda
      Next speaker
      Back
      Paul Gater
      Advocate for patients with multiple myeloma, Member of the Patient Advocate Committee SWOG Cancer Research Network (former Genentech)
      Next speaker
      Back
      Christine von Raesfeld
      Patient Advocate, The Light Collective

      Few people with a cause walk the talk as boldly and graciously as Christine Von Raesfeld, Lived Experience Expert/Citizen Scientist. Christine is a pillar of patient advocacy and allyship in the rare and chronic disease community. Through the lens of her own journey in healthcare, she has become a champion for patient voices, diversity and inclusion in clinical research, and equitable patient-sponsor partnerships.**

      A sought-after speaker, Christine brings firsthand expertise to discussions on clinical trials, data rights, and digital health. She serves as an e-patient scholar with Stanford MedicineX and a Committee Member with the Partnership for Quality Measures (CMS), among other roles. Christine advises initiatives like Stanford's "Humanwide" Precision Medicine Program, the NIH All of Us Research Program, and the NIH HEAL Initiative. She co-authored the patient-led AI Rights Initiative with The Light Collective, focusing on ethical data use and personalized medicine.

      Christine recently published a research paper analyzing her own complex medical journey[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://journal.researchtothepeople.org/christine?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 "1"), highlighting the value of patient-partnered genomics in understanding rare and chronic conditions. She has additional works on patient engagement and healthcare innovation forthcoming.

      Recognized for her contributions, she has been named one of Silicon Valley Business Journal's Top 100 Women of Influence, a Silicon Valley Community Hero, a member of the 2021 HIMSS Future50, and one of Medika Life's 50 most influential voices in healthcare.

      Session Details:

      PANEL: Breaking down silos: fostering collaboration between clinical operations and clinical supply teams

      2025-09-09, 4:00 PM

      Session Details:

      PATIENT ADVOCACY KEYNOTE: From protocols to patients: redesigning supply chains for real world impact

      2025-09-10, 12:15 PM

      Session Details:

      PANEL: Sourcing vendors and partners for your clinical supply chain: what are the most important considerations?

      2025-09-10, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Amanda Murphy
      Senior Director, Data Intelligence and Solutions,
      GlobalData Healthcare
      Next speaker
      Back
      Kirk Bray
      Senior Manager, Commercial Operations, Thermo Fisher Scientific

      Session Details:

      Biotech speed, biopharma scale: powered by clinical trial innovation

      2025-09-09, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Tom Gottschalk
      Vice President Business Development, RxStudy Card by Valeris

      Tom has worked in the life sciences industry since 1997, with the first 10 years spent as a pharmaceutical representative and marketing product manager for Bertek, Merck and GSK.

      Tom joined Valeris in 2008, created the RxStudy Card offering in 2009 and since then has been focused on changing the paradigm of the traditional clinical trial supply process to one of greater efficiency.

      Session Details:

      PRACTICAL KEYNOTE: From Concept to Clinic: Operationalizing the Pharmacy Card Model to Decentralize Supply and Accelerate Patient Access

      2026-09-22, 10:15 AM

      Session Details:

      PANEL: Clinical supply chain innovation: insights into new technology and strategy

      2025-09-09, 11:30 AM

      View In Agenda
      Next speaker

      Advisory Board

      Select a member to learn more

      Back
      Chris Wallace
      Head of Distribution EMEA, Argenx

      Chris has over 35 years’ varied supply chain experience, having worked for several blue chip companies in a number of industries including 3rd party logistics services, automotive, medical device, nuclear fuels and biotech/pharmaceuticals.

      Originally from the UK but now based in Switzerland, he has been involved in life science - biotech/pharmaceuticals & medical device - for over 20 years of his career and has latterly been SVP Global Supply Chain at Clover Biopharmaceutical before last year moving to Argenx as Head of Distribution EMEA.

      He has developed, implemented and managed global healthcare supply chain strategies and operations on 6 continents. This has included different set-ups in multiple countries, including many in the Emerging Markets as well as the developed world.

      Chris has a degree in economics from Manchester University, an MBA from Aston University and a postgraduate diploma from London University. In his spare time, he plays golf badly and loves to sample great Italian food and red wines!

      Next
      Back
      Luiz Barberini
      Head of External Manufacturing, Latin America, Bayer
      • Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
        Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
      • Demand Planning process management - pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
      • Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
      • Experience in S&OP, 3PL and Supply Chain Organization projects' implementation
      • Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
      • Solid team management skills, as well as Customer Service relationship and management
      • Teacher for major Post Graduation Schools - Demand Planning and Procurement/Negotiation areas

      CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

      Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia's Logistic Supervisor.

      Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

      Session Details:

      PANEL: Clinical supply chain innovation: insights into new technology and strategy

      2025-09-09, 11:30 AM

      Session Details:

      PANEL: Leveraging IRT and forecasting in a complex Phase 1 trial

      2025-09-10, 3:15 PM

      Session Details:

      Outsourcing and working with suppliers: making a success of your vendor relationships

      2025-09-10, 11:45 AM

      View In Agenda
      Next
      Back
      Amanda Briceno
      Clinical Supply Management & Patient Centricity Unit Manager, Chiesi Farmaceutici

      Amanda Briceno is an experienced clinical supply professional with over 10 years in clinical research and supply chain operations. Originally from Venezuela, now based in Italy. She currently serves as Clinical Supply Manager and Head of the Patient Centricity Unit at Chiesi Farmaceutici, where she leads initiatives to design and deliver patient-focused clinical supply solutions that improve trial compliance and enhance the experience of both patients and site staff.

      Her career began as a Clinical Research Associate at IQVIA, where she gained extensive experience in global trial monitoring and operations. Since joining Chiesi, Amanda has held positions of increasing responsibility within the Clinical Supply department, before assuming her current leadership role.

      Amanda holds a Master’s degree in Drug Biotechnology from the Università degli Studi di Milano and a Bachelor’s degree in Medical Biotechnology. Amanda brings a strong blend of technical knowledge and operational leadership. Passionate about innovation in clinical supplies, she is dedicated to advancing more accessible, patient-centric clinical trials.

      Next
      Back
      Paul Hingst
      Supply Chain Consultant, Crinetics Pharmaceuticals

      Paul is an experienced Clinical Supply Chain Professional with a 25-year career in the BioPharmaceutical industry.  His extensive career includes roles at major companies like Amgen and Thermo Fisher Scientific, where he honed his skills and made a significant impact.  He has served in varied roles from basic research and contract manufacturing to client services and account management.  He is a Principal Consultant and Co-Founder of Beacon BioPharm Associates, a clinical supply chain consulting firm, providing variable staffing solutions to small and mid-sized BioPharm clients.  Paul is an industry veteran and respected leader known for his expertise in clinical supply chain.

      Session Details:

      Chairperson’s closing remarks

      2025-09-09, 4:45 PM

      View In Agenda
      Next
      Back
      Amaury Jeandrain
      Strategy Advisor, Clinical Supply, N-SIDE

      Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain optimization. He joined Clinigen in 2015, then N-SIDE in 2016 where he last  held the position of VP of Strategy for clinical supply solutions.

      Over the past decade, his objective has been to make clinical trial supply chains more efficient by redefining CTS strategies and driving measurable performance improvements. His expertise also includes forecasting, planning, waste reduction, and shortage risk mitigation.

      Since 2024, while accompanying his wife on humanitarian missions abroad (Niger, then Colombia), Amaury has continued his work as a CTS advisor and trainer, partnering with pharmaceutical companies worldwide to enhance clinical supply performance.

      Next
      Back
      Arnaud Dourlens
      Global Head of Clinical Supply Chain Operations, Sanofi

      Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group.

      During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio.

      Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

      Next
      Back
      Paul Larochelle
      Senior Director Global Clinical Supply Chain,
      Takeda

      Paul Larochelle currently serves as Senior Director (Planning Team Lead) for Global Clinical Supply Chain at Takeda, where he serves as a member of the GCSC Leadership Team and is responsible for managing a team of professionals overseeing the forecasting and planning of clinical study supplies. His role encompasses the strategic and operational aspects of clinical supply chain management in therapeutic areas such as oncology, neuroscience, gastrointestinal diseases, vaccines, and rare diseases. Paul's leadership extends to cross-functional projects aimed at implementing new capabilities, conducting due diligence of potential acquisitions by the company, and improving existing processes.

      Previously, Paul held various roles at Biogen Corporation and Genzyme, a Sanofi Company, where he honed his expertise in clinical asset planning and clinical supplies management. His contributions to these organizations included serving as a lead contact for multiple clinical programs, developing supply chain strategies, leading continuous improvement projects, and serving as Fellowship Coordinator and Student Preceptor for dozens of students.

      Paul has a BS in Biology from Providence College, PharmD from MCPHS Boston, and an MBA from Worcester Polytechnic Institute. He also completed a Post-PharmD Industry Fellowship in Clinical Research/Investigational Product Management with MCPHS-Worcester and Genzyme Corporation. He is Chair of the Dean's Advisory Board at MCPHS School of Pharmacy – Boston,  a member of the Pharmacy Advisory Board at Western New England University, and a member of the Advisory Board for the Clinical Trial Supply global conference series.

      Next

      Plan Your Visit

      Venue

      Hyatt Regency San Francisco Airport 1333 Bayshore Highway Burlingame California 94010 United States

      Book Your Stay

      Accommodation

      Arena International Events Group “(Arena”) is aware of numerous third-party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings, events attendee lists and selling unsolicited services. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third-party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third-party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

      2026 Sponsors

      Select a sponsor to learn more

      Featured Sponsors

      Session sponsor

      Exhibitors

      Why partner?

       

      Contact us to become a partner

      Partnership Opportunities

      We work with you to design a bespoke package to meet your business needs, where you could:

      • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
      • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
        Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
      • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

      Event reach

      • 200+ attendees each year
      • 80% attendees C-suite level

       

      Take a look at our current sponsors

      Media Centre

      Become A Media Partner

      A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

      Simply register, login on the day and get ready to connect and learn.

      The CTS West Coast is the meeting place for pharmaceutical and biotech experts to discuss key themes and opportunities to take control and optimize clinical supply chains.

      See What It's All About

      Enquiry

      Contact Us

      SPONSORSHIP ENQUIRIES

      Jaz Sidhu

      Senior Sponsorship Manager

      +44 (0) 207 9472755

      SPEAKING OPPORTUNITIES

      Gabriela Garay Villanueva

      Portfolio Lead

      MARKETING ENQUIRIES

      Valentina Sidore

      Head of Marketing

      DELEGATE ENQUIRIES

      Sunny Saikia

      VIP Delegate Manager

      Sponsorship Enquiries

      To enquire about sponsorship opportunities for the conference, please contact:

       

      Jaz Sidhu

      Senior Sponsorship Manager


      +44 (0) 20 7947 2755

      Speaker Enquiries

      To enquire about speaking opportunities for the conference, please contact:

       

      Gabriela Garay Villanueva

      Portfolio Lead